Global Covid-19 Vaccine Market Size, Status and Forecast 2020-2026

May 2020 | 128 pages | ID: GD880C5DE9A6EN
QYResearch

Abstracts

This report focuses on the global Covid-19 Vaccine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Covid-19 Vaccine development in North America, Europe, China, Japan, South Korea, Middle East, Southeast Asia and Central & South America.

The key players covered in this study

• Inovio Pharmaceuticals
• Takis Biotech (Evvivax)
• Zydus Cadila
• Codagenix, Inc.
• GeoVax, Inc.
• Bravovax
• Janssen Pharmaceutical Companies
• Altimmune
• Vaxart
• CanSino Biologics
• ExpreS2ion Biotechnologies ApS
• Clover Biopharmaceuticals
• GSK
• Vaxil Bio Ltd.
• Generex
• Novavax, Inc.
• Sanofi Pasteur
• Baylor
• iBio, Inc.
• Zydus Cadila
• Moderna, Inc.
• Curevac
• ImmunoPrecise

Market segment by Type, the product can be split into

• DNA
• Live Attenuated Virus
• NonReplicating Viral Vecto
• Protein Subunit
• RNA

Market segment by Application, split into

• Treatment
• Prevention

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• South Korea
• Middle East
• Southeast Asia
• Central & South America

The study objectives of this report are:

• To analyze global Covid-19 Vaccine status, future forecast, growth opportunity, key market and key players.
• To present the Covid-19 Vaccine development in North America, Europe, China, Japan, South Korea, Middle East, Southeast Asia and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Covid-19 Vaccine are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Covid-19 Vaccine Revenue
1.4 Market Analysis by Type
  1.4.1 Global Covid-19 Vaccine Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 DNA
  1.4.3 Live Attenuated Virus
  1.4.4 NonReplicating Viral Vecto
  1.4.5 Protein Subunit
  1.4.6 RNA
1.5 Market by Application
  1.5.1 Global Covid-19 Vaccine Market Share by Application: 2020 VS 2026
  1.5.2 Treatment
  1.5.3 Prevention
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Covid-19 Vaccine Market Perspective (2015-2026)
2.2 Covid-19 Vaccine Growth Trends by Regions
  2.2.1 Covid-19 Vaccine Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Covid-19 Vaccine Historic Market Share by Regions (2015-2020)
  2.2.3 Covid-19 Vaccine Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Covid-19 Vaccine Market Growth Strategy
  2.3.6 Primary Interviews with Key Covid-19 Vaccine Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Covid-19 Vaccine Players by Market Size
  3.1.1 Global Top Covid-19 Vaccine Players by Revenue (2015-2020)
  3.1.2 Global Covid-19 Vaccine Revenue Market Share by Players (2015-2020)
  3.1.3 Global Covid-19 Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Covid-19 Vaccine Market Concentration Ratio
  3.2.1 Global Covid-19 Vaccine Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Covid-19 Vaccine Revenue in 2019
3.3 Covid-19 Vaccine Key Players Head office and Area Served
3.4 Key Players Covid-19 Vaccine Product Solution and Service
3.5 Date of Enter into Covid-19 Vaccine Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Covid-19 Vaccine Historic Market Size by Type (2015-2020)
4.2 Global Covid-19 Vaccine Forecasted Market Size by Type (2021-2026)

5 COVID-19 VACCINE BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Covid-19 Vaccine Market Size by Application (2015-2020)
5.2 Global Covid-19 Vaccine Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Covid-19 Vaccine Market Size (2015-2020)
6.2 Covid-19 Vaccine Key Players in North America (2019-2020)
6.3 North America Covid-19 Vaccine Market Size by Type (2015-2020)
6.4 North America Covid-19 Vaccine Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Covid-19 Vaccine Market Size (2015-2020)
7.2 Covid-19 Vaccine Key Players in Europe (2019-2020)
7.3 Europe Covid-19 Vaccine Market Size by Type (2015-2020)
7.4 Europe Covid-19 Vaccine Market Size by Application (2015-2020)

8 CHINA

8.1 China Covid-19 Vaccine Market Size (2015-2020)
8.2 Covid-19 Vaccine Key Players in China (2019-2020)
8.3 China Covid-19 Vaccine Market Size by Type (2015-2020)
8.4 China Covid-19 Vaccine Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Covid-19 Vaccine Market Size (2015-2020)
9.2 Covid-19 Vaccine Key Players in Japan (2019-2020)
9.3 Japan Covid-19 Vaccine Market Size by Type (2015-2020)
9.4 Japan Covid-19 Vaccine Market Size by Application (2015-2020)

10 SOUTH KOREA

10.1 South Korea Covid-19 Vaccine Market Size (2015-2020)
10.2 Covid-19 Vaccine Key Players in South Korea (2019-2020)
10.3 South Korea Covid-19 Vaccine Market Size by Type (2015-2020)
10.4 South Korea Covid-19 Vaccine Market Size by Application (2015-2020)

11 MIDDLE EAST

11.1 Middle East Covid-19 Vaccine Market Size (2015-2020)
11.2 Covid-19 Vaccine Key Players in Middle East (2019-2020)
11.3 Middle East Covid-19 Vaccine Market Size by Type (2015-2020)
11.4 Middle East Covid-19 Vaccine Market Size by Application (2015-2020)

12 SOUTHEAST ASIA

12.1 Southeast Asia Covid-19 Vaccine Market Size (2015-2020)
12.2 Covid-19 Vaccine Key Players in Southeast Asia (2019-2020)
12.3 Southeast Asia Covid-19 Vaccine Market Size by Type (2015-2020)
12.4 Southeast Asia Covid-19 Vaccine Market Size by Application (2015-2020)

13 CENTRAL & SOUTH AMERICA

13.1 Central & South America Covid-19 Vaccine Market Size (2015-2020)
13.2 Covid-19 Vaccine Key Players in Central & South America (2019-2020)
13.3 Central & South America Covid-19 Vaccine Market Size by Type (2015-2020)
.4 Central & South America Covid-19 Vaccine Market Size by Application (2015-2020)

14 KEY PLAYERS PROFILES

14.1 Inovio Pharmaceuticals
  14.1.1 Inovio Pharmaceuticals Company Details
  14.1.2 Inovio Pharmaceuticals Business Overview and Its Total Revenue
  14.1.3 Inovio Pharmaceuticals Covid-19 Vaccine Introduction
  14.1.4 Inovio Pharmaceuticals Revenue in Covid-19 Vaccine Business (2015-2020))
  14.1.5 Inovio Pharmaceuticals Recent Development
14.2 Takis Biotech (Evvivax)
  14.2.1 Takis Biotech (Evvivax) Company Details
  14.2.2 Takis Biotech (Evvivax) Business Overview and Its Total Revenue
  14.2.3 Takis Biotech (Evvivax) Covid-19 Vaccine Introduction
  14.2.4 Takis Biotech (Evvivax) Revenue in Covid-19 Vaccine Business (2015-2020)
  14.2.5 Takis Biotech (Evvivax) Recent Development
14.3 Zydus Cadila
  14.3.1 Zydus Cadila Company Details
  14.3.2 Zydus Cadila Business Overview and Its Total Revenue
  14.3.3 Zydus Cadila Covid-19 Vaccine Introduction
  14.3.4 Zydus Cadila Revenue in Covid-19 Vaccine Business (2015-2020)
  14.3.5 Zydus Cadila Recent Development
14.4 Codagenix, Inc.
  14.4.1 Codagenix, Inc. Company Details
  14.4.2 Codagenix, Inc. Business Overview and Its Total Revenue
  14.4.3 Codagenix, Inc. Covid-19 Vaccine Introduction
  14.4.4 Codagenix, Inc. Revenue in Covid-19 Vaccine Business (2015-2020)
  14.4.5 Codagenix, Inc. Recent Development
14.5 GeoVax, Inc.
  14.5.1 GeoVax, Inc. Company Details
  14.5.2 GeoVax, Inc. Business Overview and Its Total Revenue
  14.5.3 GeoVax, Inc. Covid-19 Vaccine Introduction
  14.5.4 GeoVax, Inc. Revenue in Covid-19 Vaccine Business (2015-2020)
  14.5.5 GeoVax, Inc. Recent Development
14.6 Bravovax
  14.6.1 Bravovax Company Details
  14.6.2 Bravovax Business Overview and Its Total Revenue
  14.6.3 Bravovax Covid-19 Vaccine Introduction
  14.6.4 Bravovax Revenue in Covid-19 Vaccine Business (2015-2020)
  14.6.5 Bravovax Recent Development
14.7 Janssen Pharmaceutical Companies
  14.7.1 Janssen Pharmaceutical Companies Company Details
  14.7.2 Janssen Pharmaceutical Companies Business Overview and Its Total Revenue
  14.7.3 Janssen Pharmaceutical Companies Covid-19 Vaccine Introduction
  14.7.4 Janssen Pharmaceutical Companies Revenue in Covid-19 Vaccine Business (2015-2020)
  14.7.5 Janssen Pharmaceutical Companies Recent Development
14.8 Altimmune
  14.8.1 Altimmune Company Details
  14.8.2 Altimmune Business Overview and Its Total Revenue
  14.8.3 Altimmune Covid-19 Vaccine Introduction
  14.8.4 Altimmune Revenue in Covid-19 Vaccine Business (2015-2020)
  14.8.5 Altimmune Recent Development
14.9 Vaxart
  14.9.1 Vaxart Company Details
  14.9.2 Vaxart Business Overview and Its Total Revenue
  14.9.3 Vaxart Covid-19 Vaccine Introduction
  14.9.4 Vaxart Revenue in Covid-19 Vaccine Business (2015-2020)
  14.9.5 Vaxart Recent Development
14.10 CanSino Biologics
  14.10.1 CanSino Biologics Company Details
  14.10.2 CanSino Biologics Business Overview and Its Total Revenue
  14.10.3 CanSino Biologics Covid-19 Vaccine Introduction
  14.10.4 CanSino Biologics Revenue in Covid-19 Vaccine Business (2015-2020)
  14.10.5 CanSino Biologics Recent Development
14.11 ExpreS2ion Biotechnologies ApS
  10.11.1 ExpreS2ion Biotechnologies ApS Company Details
  10.11.2 ExpreS2ion Biotechnologies ApS Business Overview and Its Total Revenue
  10.11.3 ExpreS2ion Biotechnologies ApS Covid-19 Vaccine Introduction
  10.11.4 ExpreS2ion Biotechnologies ApS Revenue in Covid-19 Vaccine Business (2015-2020)
  10.11.5 ExpreS2ion Biotechnologies ApS Recent Development
14.12 Clover Biopharmaceuticals
  10.12.1 Clover Biopharmaceuticals Company Details
  10.12.2 Clover Biopharmaceuticals Business Overview and Its Total Revenue
  10.12.3 Clover Biopharmaceuticals Covid-19 Vaccine Introduction
  10.12.4 Clover Biopharmaceuticals Revenue in Covid-19 Vaccine Business (2015-2020)
  10.12.5 Clover Biopharmaceuticals Recent Development
14.13 GSK
  10.13.1 GSK Company Details
  10.13.2 GSK Business Overview and Its Total Revenue
  10.13.3 GSK Covid-19 Vaccine Introduction
  10.13.4 GSK Revenue in Covid-19 Vaccine Business (2015-2020)
  10.13.5 GSK Recent Development
14.14 Vaxil Bio Ltd.
  10.14.1 Vaxil Bio Ltd. Company Details
  10.14.2 Vaxil Bio Ltd. Business Overview and Its Total Revenue
  10.14.3 Vaxil Bio Ltd. Covid-19 Vaccine Introduction
  10.14.4 Vaxil Bio Ltd. Revenue in Covid-19 Vaccine Business (2015-2020)
  10.14.5 Vaxil Bio Ltd. Recent Development
14.15 Generex
  10.15.1 Generex Company Details
  10.15.2 Generex Business Overview and Its Total Revenue
  10.15.3 Generex Covid-19 Vaccine Introduction
  10.15.4 Generex Revenue in Covid-19 Vaccine Business (2015-2020)
  10.15.5 Generex Recent Development
14.16 Novavax, Inc.
  10.16.1 Novavax, Inc. Company Details
  10.16.2 Novavax, Inc. Business Overview and Its Total Revenue
  10.16.3 Novavax, Inc. Covid-19 Vaccine Introduction
  10.16.4 Novavax, Inc. Revenue in Covid-19 Vaccine Business (2015-2020)
  10.16.5 Novavax, Inc. Recent Development
14.17 Sanofi Pasteur
  10.17.1 Sanofi Pasteur Company Details
  10.17.2 Sanofi Pasteur Business Overview and Its Total Revenue
  10.17.3 Sanofi Pasteur Covid-19 Vaccine Introduction
  10.17.4 Sanofi Pasteur Revenue in Covid-19 Vaccine Business (2015-2020)
  10.17.5 Sanofi Pasteur Recent Development
14.18 Baylor
  10.18.1 Baylor Company Details
  10.18.2 Baylor Business Overview and Its Total Revenue
  10.18.3 Baylor Covid-19 Vaccine Introduction
  10.18.4 Baylor Revenue in Covid-19 Vaccine Business (2015-2020)
  10.18.5 Baylor Recent Development
14.19 iBio, Inc.
  10.19.1 iBio, Inc. Company Details
  10.19.2 iBio, Inc. Business Overview and Its Total Revenue
  10.19.3 iBio, Inc. Covid-19 Vaccine Introduction
  10.19.4 iBio, Inc. Revenue in Covid-19 Vaccine Business (2015-2020)
  10.19.5 iBio, Inc. Recent Development
14.20 Zydus Cadila
  10.20.1 Zydus Cadila Company Details
  10.20.2 Zydus Cadila Business Overview and Its Total Revenue
  10.20.3 Zydus Cadila Covid-19 Vaccine Introduction
  10.20.4 Zydus Cadila Revenue in Covid-19 Vaccine Business (2015-2020)
  10.20.5 Zydus Cadila Recent Development
14.21 Moderna, Inc.
  10.21.1 Moderna, Inc. Company Details
  10.21.2 Moderna, Inc. Business Overview and Its Total Revenue
  10.21.3 Moderna, Inc. Covid-19 Vaccine Introduction
  10.21.4 Moderna, Inc. Revenue in Covid-19 Vaccine Business (2015-2020)
  10.21.5 Moderna, Inc. Recent Development
14.22 Curevac
  10.22.1 Curevac Company Details
  10.22.2 Curevac Business Overview and Its Total Revenue
  10.22.3 Curevac Covid-19 Vaccine Introduction
  10.22.4 Curevac Revenue in Covid-19 Vaccine Business (2015-2020)
  10.22.5 Curevac Recent Development
14.23 ImmunoPrecise
  10.23.1 ImmunoPrecise Company Details
  10.23.2 ImmunoPrecise Business Overview and Its Total Revenue
  10.23.3 ImmunoPrecise Covid-19 Vaccine Introduction
  10.23.4 ImmunoPrecise Revenue in Covid-19 Vaccine Business (2015-2020)
  10.23.5 ImmunoPrecise Recent Development

15 ANALYST'S VIEWPOINTS/CONCLUSIONS

16 APPENDIX

16.1 Research Methodology
  16.1.1 Methodology/Research Approach
  16.1.2 Data Source
16.2 Disclaimer
16.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Covid-19 Vaccine Key Market Segments
Table 2. Key Players Covered: Ranking by Covid-19 Vaccine Revenue
Table 3. Ranking of Global Top Covid-19 Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Covid-19 Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of DNA
Table 6. Key Players of Live Attenuated Virus
Table 7. Key Players of NonReplicating Viral Vecto
Table 8. Key Players of Protein Subunit
Table 9. Key Players of RNA
Table 10. Global Covid-19 Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Covid-19 Vaccine Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Covid-19 Vaccine Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Covid-19 Vaccine Market Share by Regions (2015-2020)
Table 14. Global Covid-19 Vaccine Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Covid-19 Vaccine Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Covid-19 Vaccine Market Growth Strategy
Table 20. Main Points Interviewed from Key Covid-19 Vaccine Players
Table 21. Global Covid-19 Vaccine Revenue by Players (2015-2020) (Million US$)
Table 22. Global Covid-19 Vaccine Market Share by Players (2015-2020)
Table 23. Global Top Covid-19 Vaccine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Covid-19 Vaccine as of 2019)
Table 24. Global Covid-19 Vaccine by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Covid-19 Vaccine Product Solution and Service
Table 27. Date of Enter into Covid-19 Vaccine Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Covid-19 Vaccine Market Size by Type (2015-2020) (Million US$)
Table 30. Global Covid-19 Vaccine Market Size Share by Type (2015-2020)
Table 31. Global Covid-19 Vaccine Revenue Market Share by Type (2021-2026)
Table 32. Global Covid-19 Vaccine Market Size Share by Application (2015-2020)
Table 33. Global Covid-19 Vaccine Market Size by Application (2015-2020) (Million US$)
Table 34. Global Covid-19 Vaccine Market Size Share by Application (2021-2026)
Table 35. North America Key Players Covid-19 Vaccine Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Covid-19 Vaccine Market Share (2019-2020)
Table 37. North America Covid-19 Vaccine Market Size by Type (2015-2020) (Million US$)
Table 38. North America Covid-19 Vaccine Market Share by Type (2015-2020)
Table 39. North America Covid-19 Vaccine Market Size by Application (2015-2020) (Million US$)
Table 40. North America Covid-19 Vaccine Market Share by Application (2015-2020)
Table 41. Europe Key Players Covid-19 Vaccine Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Covid-19 Vaccine Market Share (2019-2020)
Table 43. Europe Covid-19 Vaccine Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Covid-19 Vaccine Market Share by Type (2015-2020)
Table 45. Europe Covid-19 Vaccine Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Covid-19 Vaccine Market Share by Application (2015-2020)
Table 47. China Key Players Covid-19 Vaccine Revenue (2019-2020) (Million US$)
Table 48. China Key Players Covid-19 Vaccine Market Share (2019-2020)
Table 49. China Covid-19 Vaccine Market Size by Type (2015-2020) (Million US$)
Table 50. China Covid-19 Vaccine Market Share by Type (2015-2020)
Table 51. China Covid-19 Vaccine Market Size by Application (2015-2020) (Million US$)
Table 52. China Covid-19 Vaccine Market Share by Application (2015-2020)
Table 53. Japan Key Players Covid-19 Vaccine Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Covid-19 Vaccine Market Share (2019-2020)
Table 55. Japan Covid-19 Vaccine Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Covid-19 Vaccine Market Share by Type (2015-2020)
Table 57. Japan Covid-19 Vaccine Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Covid-19 Vaccine Market Share by Application (2015-2020)
Table 59. South Korea Key Players Covid-19 Vaccine Revenue (2019-2020) (Million US$)
Table 60. South Korea Key Players Covid-19 Vaccine Market Share (2019-2020)
Table 61. South Korea Covid-19 Vaccine Market Size by Type (2015-2020) (Million US$)
Table 62. South Korea Covid-19 Vaccine Market Share by Type (2015-2020)
Table 63. South Korea Covid-19 Vaccine Market Size by Application (2015-2020) (Million US$)
Table 64. South Korea Covid-19 Vaccine Market Share by Application (2015-2020)
Table 65. Middle East Key Players Covid-19 Vaccine Revenue (2019-2020) (Million US$)
Table 66. Middle East Key Players Covid-19 Vaccine Market Share (2019-2020)
Table 67. Middle East Covid-19 Vaccine Market Size by Type (2015-2020) (Million US$)
Table 68. Middle East Covid-19 Vaccine Market Share by Type (2015-2020)
Table 69. Middle East Covid-19 Vaccine Market Size by Application (2015-2020) (Million US$)
Table 70. Middle East Covid-19 Vaccine Market Share by Application (2015-2020)
Table 71. Southeast Asia Key Players Covid-19 Vaccine Revenue (2019-2020) (Million US$)
Table 72. Southeast Asia Key Players Covid-19 Vaccine Market Share (2019-2020)
Table 73. Southeast Asia Covid-19 Vaccine Market Size by Type (2015-2020) (Million US$)
Table 74. Southeast Asia Covid-19 Vaccine Market Share by Type (2015-2020)
Table 75. Southeast Asia Covid-19 Vaccine Market Size by Application (2015-2020) (Million US$)
Table 76. Southeast Asia Covid-19 Vaccine Market Share by Application (2015-2020)
Table 77. Central & South America Key Players Covid-19 Vaccine Revenue (2019-2020) (Million US$)
Table 78. Central & South America Key Players Covid-19 Vaccine Market Share (2019-2020)
Table 79. Central & South America Covid-19 Vaccine Market Size by Type (2015-2020) (Million US$)
Table 80. Central & South America Covid-19 Vaccine Market Share by Type (2015-2020)
Table 81. Central & South America Covid-19 Vaccine Market Size by Application (2015-2020) (Million US$)
Table 82. Central & South America Covid-19 Vaccine Market Share by Application (2015-2020)
Table 83. Inovio Pharmaceuticals Company Details
Table 84. Inovio Pharmaceuticals Business Overview
Table 85. Inovio Pharmaceuticals Product
Table 86. Inovio Pharmaceuticals Revenue in Covid-19 Vaccine Business (2015-2020) (Million US$)
Table 87. Inovio Pharmaceuticals Recent Development
Table 88. Takis Biotech (Evvivax) Company Details
Table 89. Takis Biotech (Evvivax) Business Overview
Table 90. Takis Biotech (Evvivax) Product
Table 91. Takis Biotech (Evvivax) Revenue in Covid-19 Vaccine Business (2015-2020) (Million US$)
Table 92. Takis Biotech (Evvivax) Recent Development
Table 93. Zydus Cadila Company Details
Table 94. Zydus Cadila Business Overview
Table 95. Zydus Cadila Product
Table 96. Zydus Cadila Revenue in Covid-19 Vaccine Business (2015-2020) (Million US$)
Table 97. Zydus Cadila Recent Development
Table 98. Codagenix, Inc. Company Details
Table 99. Codagenix, Inc. Business Overview
Table 100. Codagenix, Inc. Product
Table 101. Codagenix, Inc. Revenue in Covid-19 Vaccine Business (2015-2020) (Million US$)
Table 102. Codagenix, Inc. Recent Development
Table 103. GeoVax, Inc. Company Details
Table 104. GeoVax, Inc. Business Overview
Table 105. GeoVax, Inc. Product
Table 106. GeoVax, Inc. Revenue in Covid-19 Vaccine Business (2015-2020) (Million US$)
Table 107. GeoVax, Inc. Recent Development
Table 108. Bravovax Company Details
Table 109. Bravovax Business Overview
Table 110. Bravovax Product
Table 111. Bravovax Revenue in Covid-19 Vaccine Business (2015-2020) (Million US$)
Table 112. Bravovax Recent Development
Table 113. Janssen Pharmaceutical Companies Company Details
Table 114. Janssen Pharmaceutical Companies Business Overview
Table 115. Janssen Pharmaceutical Companies Product
Table 116. Janssen Pharmaceutical Companies Revenue in Covid-19 Vaccine Business (2015-2020) (Million US$)
Table 117. Janssen Pharmaceutical Companies Recent Development
Table 118. Altimmune Business Overview
Table 119. Altimmune Product
Table 120. Altimmune Company Details
Table 121. Altimmune Revenue in Covid-19 Vaccine Business (2015-2020) (Million US$)
Table 122. Altimmune Recent Development
Table 123. Vaxart Company Details
Table 124. Vaxart Business Overview
Table 125. Vaxart Product
Table 126. Vaxart Revenue in Covid-19 Vaccine Business (2015-2020) (Million US$)
Table 127. Vaxart Recent Development
Table 128. CanSino Biologics Company Details
Table 129. CanSino Biologics Business Overview
Table 130. CanSino Biologics Product
Table 131. CanSino Biologics Revenue in Covid-19 Vaccine Business (2015-2020) (Million US$)
Table 132. CanSino Biologics Recent Development
Table 133. ExpreS2ion Biotechnologies ApS Company Details
Table 134. ExpreS2ion Biotechnologies ApS Business Overview
Table 135. ExpreS2ion Biotechnologies ApS Product
Table 136. ExpreS2ion Biotechnologies ApS Revenue in Covid-19 Vaccine Business (2015-2020) (Million US$)
Table 137. ExpreS2ion Biotechnologies ApS Recent Development
Table 138. Clover Biopharmaceuticals Company Details
Table 139. Clover Biopharmaceuticals Business Overview
Table 140. Clover Biopharmaceuticals Product
Table 141. Clover Biopharmaceuticals Revenue in Covid-19 Vaccine Business (2015-2020) (Million US$)
Table 142. Clover Biopharmaceuticals Recent Development
Table 143. GSK Company Details
Table 144. GSK Business Overview
Table 145. GSK Product
Table 146. GSK Revenue in Covid-19 Vaccine Business (2015-2020) (Million US$)
Table 147. GSK Recent Development
Table 148. Vaxil Bio Ltd. Company Details
Table 149. Vaxil Bio Ltd. Business Overview
Table 150. Vaxil Bio Ltd. Product
Table 151. Vaxil Bio Ltd. Revenue in Covid-19 Vaccine Business (2015-2020) (Million US$)
Table 152. Vaxil Bio Ltd. Recent Development
Table 153. Generex Company Details
Table 154. Generex Business Overview
Table 155. Generex Product
Table 156. Generex Revenue in Covid-19 Vaccine Business (2015-2020) (Million US$)
Table 157. Generex Recent Development
Table 158. Novavax, Inc. Company Details
Table 159. Novavax, Inc. Business Overview
Table 160. Novavax, Inc. Product
Table 161. Novavax, Inc. Revenue in Covid-19 Vaccine Business (2015-2020) (Million US$)
Table 162. Novavax, Inc. Recent Development
Table 163. Sanofi Pasteur Company Details
Table 164. Sanofi Pasteur Business Overview
Table 165. Sanofi Pasteur Product
Table 166. Sanofi Pasteur Revenue in Covid-19 Vaccine Business (2015-2020) (Million US$)
Table 167. Sanofi Pasteur Recent Development
Table 168. Baylor Company Details
Table 169. Baylor Business Overview
Table 170. Baylor Product
Table 171. Baylor Revenue in Covid-19 Vaccine Business (2015-2020) (Million US$)
Table 172. Baylor Recent Development
Table 173. iBio, Inc. Company Details
Table 174. iBio, Inc. Business Overview
Table 175. iBio, Inc. Product
Table 176. iBio, Inc. Revenue in Covid-19 Vaccine Business (2015-2020) (Million US$)
Table 177. iBio, Inc. Recent Development
Table 178. Zydus Cadila Company Details
Table 179. Zydus Cadila Business Overview
Table 180. Zydus Cadila Product
Table 181. Zydus Cadila Revenue in Covid-19 Vaccine Business (2015-2020) (Million US$)
Table 182. Zydus Cadila Recent Development
Table 183. Moderna, Inc. Company Details
Table 184. Moderna, Inc. Business Overview
Table 185. Moderna, Inc. Product
Table 186. Moderna, Inc. Revenue in Covid-19 Vaccine Business (2015-2020) (Million US$)
Table 187. Moderna, Inc. Recent Development
Table 188. Curevac Company Details
Table 189. Curevac Business Overview
Table 190. Curevac Product
Table 191. Curevac Revenue in Covid-19 Vaccine Business (2015-2020) (Million US$)
Table 192. Curevac Recent Development
Table 193. ImmunoPrecise Company Details
Table 194. ImmunoPrecise Business Overview
Table 195. ImmunoPrecise Product
Table 196. ImmunoPrecise Revenue in Covid-19 Vaccine Business (2015-2020) (Million US$)
Table 197. ImmunoPrecise Recent Development
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Covid-19 Vaccine Market Share by Type: 2020 VS 2026
Figure 2. DNA Features
Figure 3. Live Attenuated Virus Features
Figure 4. NonReplicating Viral Vecto Features
Figure 5. Protein Subunit Features
Figure 6. RNA Features
Figure 7. Global Covid-19 Vaccine Market Share by Application: 2020 VS 2026
Figure 8. Treatment Case Studies
Figure 9. Prevention Case Studies
Figure 10. Covid-19 Vaccine Report Years Considered
Figure 11. Global Covid-19 Vaccine Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Covid-19 Vaccine Market Share by Regions: 2020 VS 2026
Figure 13. Global Covid-19 Vaccine Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Covid-19 Vaccine Market Share by Players in 2019
Figure 16. Global Top Covid-19 Vaccine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Covid-19 Vaccine as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Covid-19 Vaccine Revenue in 2019
Figure 18. North America Covid-19 Vaccine Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Covid-19 Vaccine Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Covid-19 Vaccine Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Covid-19 Vaccine Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. South Korea Covid-19 Vaccine Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Middle East Covid-19 Vaccine Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Covid-19 Vaccine Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Covid-19 Vaccine Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Inovio Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Inovio Pharmaceuticals Revenue Growth Rate in Covid-19 Vaccine Business (2015-2020)
Figure 28. Takis Biotech (Evvivax) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Takis Biotech (Evvivax) Revenue Growth Rate in Covid-19 Vaccine Business (2015-2020)
Figure 30. Zydus Cadila Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Zydus Cadila Revenue Growth Rate in Covid-19 Vaccine Business (2015-2020)
Figure 32. Codagenix, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Codagenix, Inc. Revenue Growth Rate in Covid-19 Vaccine Business (2015-2020)
Figure 34. GeoVax, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. GeoVax, Inc. Revenue Growth Rate in Covid-19 Vaccine Business (2015-2020)
Figure 36. Bravovax Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Bravovax Revenue Growth Rate in Covid-19 Vaccine Business (2015-2020)
Figure 38. Janssen Pharmaceutical Companies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Janssen Pharmaceutical Companies Revenue Growth Rate in Covid-19 Vaccine Business (2015-2020)
Figure 40. Altimmune Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Altimmune Revenue Growth Rate in Covid-19 Vaccine Business (2015-2020)
Figure 42. Vaxart Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Vaxart Revenue Growth Rate in Covid-19 Vaccine Business (2015-2020)
Figure 44. CanSino Biologics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. CanSino Biologics Revenue Growth Rate in Covid-19 Vaccine Business (2015-2020)
Figure 46. ExpreS2ion Biotechnologies ApS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. ExpreS2ion Biotechnologies ApS Revenue Growth Rate in Covid-19 Vaccine Business (2015-2020)
Figure 48. Clover Biopharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Clover Biopharmaceuticals Revenue Growth Rate in Covid-19 Vaccine Business (2015-2020)
Figure 50. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. GSK Revenue Growth Rate in Covid-19 Vaccine Business (2015-2020)
Figure 52. Vaxil Bio Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Vaxil Bio Ltd. Revenue Growth Rate in Covid-19 Vaccine Business (2015-2020)
Figure 54. Generex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Generex Revenue Growth Rate in Covid-19 Vaccine Business (2015-2020)
Figure 56. Novavax, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Novavax, Inc. Revenue Growth Rate in Covid-19 Vaccine Business (2015-2020)
Figure 58. Sanofi Pasteur Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Sanofi Pasteur Revenue Growth Rate in Covid-19 Vaccine Business (2015-2020)
Figure 60. Baylor Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Baylor Revenue Growth Rate in Covid-19 Vaccine Business (2015-2020)
Figure 62. iBio, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. iBio, Inc. Revenue Growth Rate in Covid-19 Vaccine Business (2015-2020)
Figure 64. Zydus Cadila Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Zydus Cadila Revenue Growth Rate in Covid-19 Vaccine Business (2015-2020)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation